Pharm Final 1A Flashcards
Paradoxical bradycardia may occur if atropine is given:
A. in doses less than 0.1 mg. B. in doses greater than 2 mg. C. too rapidly. D. for acetylcholinesterase inhibition.
A
Unlike Schedule I drugs, Schedule II drugs have:
A. no accepted medical application. B. accepted medical uses. C. limited dependence potential. D. a higher abuse potential.
B
A patient takes 500 mg of a medication that has a half-life of 2 hours. How much medication will be in the patient’s body after 6 hours?
A. 250 mg B. 125 mg C. 31.25 mg D. 62.5 mg
D
Which of the following medications possesses positive inotropic effects, allows the cellular uptake of glucose, and is used in the treatment of hyperkalemia?
A. Glucophage B. Insulin C. Clopidogrel D. Osmitrol
B
All of the following are common sites for emergency IO cannulation, EXCEPT the:
A. iliac crest. B. proximal tibia. C. manubrium. D. proximal humerus.
A
Stimulation of alpha-1 receptors results in:
A. glucagon secretion. B. vasoconstriction. C. insulin secretion. D. arterial dilation.
B
Decreased efficacy or potency of a medication when taken repeatedly by a patient is called:
A. tolerance. B. immunity. C. habituation. D. addiction.
A
Medication X is given to increase the effects of medication Y, which provides more relief than if medication Y were given alone. This is an example of:
A. synergism. B. potentiation. C. summation. D. antagonism.
B
The process that the cells of large medication molecules use to ingest intracellular fluids and their contents is called:
A. filtration. B. osmosis. C. pinocytosis. D. phagocytosis.
C
A drug is assigned a pregnancy category “A” if:
A. studies in animals have revealed adverse effects on the fetus and there are no controlled studies in women, or studies in women and animals are not available. B. there is evidence of fetal risk based on human experience, and the risk of using the drug in pregnant women clearly outweighs any possible benefit. C. controlled studies in women fail to demonstrate a risk to the fetus in the first trimester, there is no evidence of risk in later trimesters, and the possibility of fetal harm appears remote. D. there is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the documented risk.
C
In order to cause a negative inotropic effect on the heart, you would have to administer a :
A. alpha-2 adrenergic agonist. B. alpha-1 adrenergic antagonist. C. beta-2 adrenergic agonist. D. beta-1 adrenergic antagonist.
D
Most medication biotransformation occurs in the:
A. kidneys. B. GI tract. C. liver. D. lungs.
C
Stimulation of alpha-2 receptors:
A. causes profound systemic hypertension. B. increases the release of norepinephrine. C. constricts the vascular smooth muscle. D. suppresses the release of norepinephrine.
D
Under normal conditions, the renin-angiotensin system functions by:
A. dilating the systemic vasculature and reducing cardiac afterload when arterial blood pressure increases. B. blocking alpha-2 receptors, thereby increasing the release of norepinephrine and raising blood pressure. C. promoting vasoconstriction and fluid retention in response to hypotension or hypoperfusion. D. stimulating alpha-1 receptors, thereby increasing the blood pressure in response to acute blood loss.
C
The United States Pharmacopeia (USP) recommended temperature range for MOST medications in the prehospital setting is:
A. 55°F to 86°F. B. 45°F to 80°F. C. 60°F to 90°F. D. 40°F to 76°F.
A